SG Americas Securities’s Ascendis Pharma ASND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$2.92M Buy
+16,915
New +$2.92M 0.01% 571
2025
Q1
Sell
-33,944
Closed -$4.67M 3007
2024
Q4
$4.67M Buy
33,944
+31,723
+1,428% +$4.37M 0.02% 324
2024
Q3
$332K Sell
2,221
-3,887
-64% -$581K ﹤0.01% 1819
2024
Q2
$833K Buy
6,108
+4,205
+221% +$573K ﹤0.01% 1286
2024
Q1
$288K Buy
+1,903
New +$288K ﹤0.01% 1528
2023
Q2
Sell
-46,347
Closed -$4.97M 1968
2023
Q1
$4.97M Buy
46,347
+25,417
+121% +$2.73M 0.06% 238
2022
Q4
$2.56M Buy
20,930
+19,838
+1,817% +$2.42M 0.03% 392
2022
Q3
$113K Buy
+1,092
New +$113K ﹤0.01% 2477
2022
Q2
Sell
-942
Closed -$111K 3040
2022
Q1
$111K Buy
942
+142
+18% +$16.7K ﹤0.01% 2424
2021
Q4
$108K Sell
800
-2,454
-75% -$331K ﹤0.01% 2746
2021
Q3
$519K Buy
3,254
+727
+29% +$116K ﹤0.01% 2263
2021
Q2
$332K Buy
+2,527
New +$332K ﹤0.01% 1915
2021
Q1
Sell
-1,971
Closed -$329K 2898
2020
Q4
$329K Buy
1,971
+804
+69% +$134K ﹤0.01% 2023
2020
Q3
$180K Buy
+1,167
New +$180K ﹤0.01% 1844
2020
Q2
Sell
-2,213
Closed -$249K 3139
2020
Q1
$249K Sell
2,213
-1,758
-44% -$198K ﹤0.01% 1967
2019
Q4
$552K Sell
3,971
-6,175
-61% -$858K 0.01% 1459
2019
Q3
$977K Sell
10,146
-2,881
-22% -$277K 0.01% 1239
2019
Q2
$1.5M Buy
13,027
+10,939
+524% +$1.26M 0.01% 1084
2019
Q1
$246K Buy
2,088
+234
+13% +$27.6K ﹤0.01% 2122
2018
Q4
$116K Buy
+1,854
New +$116K ﹤0.01% 2249
2018
Q3
Sell
-11,461
Closed -$762K 2568
2018
Q2
$762K Buy
+11,461
New +$762K 0.01% 1505